Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medicinal cannabis dose-finding in paediatric palliative care for advanced cancer
ACTRN12622000037707Phase 3Recruiting
- Sponsor
- Queensland University of Technology
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dronabinol and cannabidiol in cancer (2 arms), sponsored by Queensland University of Technology. Primary endpoint: Change in total symptom burden. Started Jun 2024; status: recruiting.
02
Drugs
dronabinolcannabidiol
03
Conditions
cancer
Beyond the preview
Go deeper on ACTRN12622000037707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622000037707.